SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2021 / Cilt: 19 - Sayı: 1

Hearing Assessment in Adult Patients with Common Variable Immunodeficiency

Gökhan AYTEKİN
Fatih ÇÖLKESEN
Eray YILDIZ
Mitat ARICIGİL
Şevket ARSLAN
Pages
38–45
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They provide evidence for thenotion that these two types of hearing loss are not unrelated, immune dysregulation also plays a role in the process, and SNHL is notindependent of CHL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Common Variable Immunodeficiency (CVID) is a primary antibody disorder characterized by impaired B cell differentiation.Patients commonly present with acute and chronic sinusitis as well as otitis media, which may lead to hearing loss.Materials and Methods: Thirty-three CVID patients (20 male /13 female) with a mean age of 35 years (range 19-65 years) and 33healthy individuals as a control group were included.Results: Among CVID patients, 17 (51.5%) had conductive hearing loss (CHL) , being unilateral in 4 (12.1%) and bilateral in 13 (39.4%).Unilateral and bilateral sensorineural hearing loss (SNHL) were detected in 2 (6.1%) and 5 (15.2%) respectively.
📊
Key Findings & Data:CD4/CD8 cell ratio wassignificantly lower while CD8+ T lymphocyte ratio was significantly higher in those with CHL than in those without it (p=0.045 andp=0.009).
💡
Conclusion & Impact:They provide evidence for thenotion that these two types of hearing loss are not unrelated, immune dysregulation also plays a role in the process, and SNHL is notindependent of CHL.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Common Variable Immunodeficiency (CVID) is a primary antibody disorder characterized by impaired B cell differentiation.Patients commonly present with acute and chronic sinusitis as well as otitis media, which may lead to hearing loss.Materials and Methods: Thirty-three CVID patients (20 male /13 female) with a mean age of 35 years (range 19-65 years) and 33healthy individuals as a control group were included.Results: Among CVID patients, 17 (51.5%) had conductive hearing loss (CHL) , being unilateral in 4 (12.1%) and bilateral in 13 (39.4%).Unilateral and bilateral sensorineural hearing loss (SNHL) were detected in 2 (6.1%) and 5 (15.2%) respectively. CD4/CD8 cell ratio wassignificantly lower while CD8+ T lymphocyte ratio was significantly higher in those with CHL than in those without it (p=0.045 andp=0.009). Elevated CD8+ T cell ratio was an independent risk factor for CHL (p=0.015). Patients with SNHL were significantly olderthan those without it (p=0.040). CD16-56+ cell count was significantly lower in those with SNHL (p=0.031).Conclusion: CVID patients have an increased occurrence of CHL and SNHL, regardless of the cause. They provide evidence for thenotion that these two types of hearing loss are not unrelated, immune dysregulation also plays a role in the process, and SNHL is notindependent of CHL.

🔖

Cite This Article

AYTEKİN, G., ÇÖLKESEN, F., YILDIZ, E., ARICIGİL, M., ARSLAN, Ş. (2021). Hearing Assessment in Adult Patients with Common Variable Immunodeficiency. Astım Allerji İmmünoloji, Cilt: 19 - Sayı: 1, 38–45. https://ajindex.com/articles/351200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34-48
  2. Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-7
  3. Kainulainen L, Suonpaa J, Nikoskelainen J, et al. Bacteria and viruses in maxillary sinuses of patients with primary hypogammaglobulinemia. Arch Otolaryngol Head Neck Surg. 2007;133(6):597-602
  4. Tavakol M, Kouhi A, Abolhassani H, et al. Otological findings in pediatric patients with hypogammaglobulinemia. Iran J Allergy Asthma Immunol. 2014;13(3):166-73
  5. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190-7
  6. Eski E, Usta BE, Asilsoy S, et al. Sensorineural Hearing Loss in Selective Immunglobulin A Deficiency. Turk Arch Otorhinolaryngol. 2017;55(1):31-33
  7. Bertoli LF, Pappas DG, Barton JC, et al. Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: Increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3. BMC Immunology. 2014;15:43
  8. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979;88(5 Pt 1):585-9
  9. Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12(5):426-30
  10. Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: Introduction, methodology, and recommendations. Otolaryngol Head Neck Surg. 2004;130(3 Suppl):S51-6
  11. Arnold W, Pfaltz R, Altermatt HJ. Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol. 1985;99(3- 4):437-44
  12. Berlucchi M, Soresina A, Redaelli De Zinis LO, et al. Sensorineural hearing loss in primary antibody deficiency disorders. J Pediatr. 2008;153(2):293-6
  13. Tahiat A, Djidjik R, Boushaki S, et al. Common variable immunodeficiency (CVID): Clinical and immunological features of 29 Algerian patients. Pathol Biol (Paris). 2014;62(6):377-81
  14. Gregersen S, Holm AM, Fevang B, et al. Lung disease, T-cells and inflammation in common variable immunodeficiency disorders. Scand J Clin Lab Invest. 2013;73(6):514-22
  15. Mokhtari M, Shakeri A, Mirminachi B, et al. Importan